Use of intravenous hyoscine butylbromide (Buscopan) during gastrointestinal endoscopy

Frontline Gastroenterol. 2018 Jul;9(3):183-184. doi: 10.1136/flgastro-2017-100877. Epub 2017 Aug 18.

Thomas Lee^{1

2}, John Anderson^{3

4}, Siwan Thomas-Gibson^{5

6

7}, Colin Rees^{2

8

9

10}

¹ Gastroenterology, Northumbria Healthcare NHS Foundation Trust, UK.
² Northern Region Endoscopy Group (NREG), Newcastle, UK.
³ Department of Gastroenterology, Cheltenham General Hospital, Cheltenham, UK.
⁴ Bowel Cancer Screening Programme Accreditation Panel, London, UK.
⁵ Wolfson Unit for Endoscopy, St Mark's Hospital, London, UK.
⁶ Surgery, Imperial College, London, UK.
⁷ Joint Advisory Group (on Gastrointestinal Endoscopy), London, UK.
⁸ Department of Gastroenterology, South Tyneside General Hospital, South Shields, UK.
⁹ British Society of Gastroenterology, London, UK.
¹⁰ Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.

No abstract available

Keywords: adverse drug reactions; colonic polyps; colonoscopy; endoscopic retrograde pancreatography; endoscopy.

Publication types